MGLL and neuropathic pain: Having established that LEI-515 mimics the effects of irreversible MAGL inhibitors in a liver injury model, we investigated whether peripheral MAGL inhibition would suppress behavioural sensitization in a chemotherapy-induced neuropathic pain model without inducing CNS-mediated adverse effects.